MAGNEGAS CORPORATION (Exact name of registrant as specified in its charter)

Transcription

1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2017 MAGNEGAS CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction (Commission File Number) (IRS Employee of incorporation) Identification No.) th Street North Clearwater, FL (Address of principal executive offices) (Zip Code) Registrant s telephone number, including area code: (727) Not applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

2 Item 7.01 Regulation FD Disclosure. On September 11, 2017, MagneGas Corporation ( Company ) will deliver a presentation at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 10-12, 2017 at Lotte New York Palace Hotel in New York, New York. The materials included in Exhibit 99.1 to this report (the Investor Presentation ) will be used in the presentation. Senior management and certain members of the Company have begun using the Investor Presentation in connection with presentations to existing shareholders and potential investors of the Company. The Investor Presentation is incorporated into this Item 7.01 by reference and will be available on the Company s website at Without limiting the generality of the foregoing, the Forward-Looking Statements disclosure contained in the investor presentation is incorporated by reference into this Item The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed to be filed for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and such information is not incorporated by reference into any registration statements or other document filed under the Securities Act of 1933, as amended or the Exchange Act, regardless of the general incorporation language contained in such filing, except as shall be expressly set forth by specific reference to this filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description Exhibit 99.1 MagneGas Corporation Investor Presentation (Revised September 2017) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 11, 2017 MAGNEGAS CORPORATION /s/ermanno Santilli By: Ermanno Santilli Its: Chief Executive Officer

3 MagneGas Corporation Investor Presentation September 2017 Scott Mahoney, CFA Chief Financial Officer Exhibit 99.1

4 MagneGas Corporate Overview Founded in 2007, based in Tampa, Florida. 40 Employees. Core technology was initially developed to produce a low - cost renewable fuel source. 30+ years to develop and patent. MagneGas has two current commercial applications, and many more potential applications being researched for future value. Commercially active, selling into the US & EU industrial gas, US agriculture, and EU landfill industries. NASDAQ:MNGA

5 MagneCule: Theory With Commercial Potential Plasma Arc Flow System is believed to alter the atomic bonding of certain materials exposed to the Arc. We believe the atomic structure of the materials exposed to the Plasma Arc change from a spherical shape to an ionized valence bond Possibly explains the behavior that our gases combust at disproportionately higher temperatures. Researching impact to flame speed. MagneGas holds a patent on the use of MagneCules for a variety of end - use applications. NASDAQ:MNGA

6 MagneGas Technology 30 Patents and patent applications. Multiple trade secrets. Multiple applications can leverage this proprietary technology. + Only known patented submerged plasma arc solution. Current Commercial Applications: Manufacture a renewable acetylene replacement fuel Sterilization of liquefied waste NASDAQ:MNGA

7 Technology Overview Liquid Biomass* Sewage, Sludge, Manure, Wasted oils. (adjustable to customers feedstock) Plasma Arc Through Technology TM 2 carbon electrodes housed inside (proprietary) Liquid Biomass is hyper heated releasing MagneGas TM Storage of MagneGas TM Ready to be shipped for all applications Power Electronic Management (Patented) Carbon Residue Can be burned or used as fertilizer * Certain liquids require dilution or further testing NASDAQ:MNGA

8 MagneGas 2 TM : A Disruptive Technology MagneGas 2 is the only known renewable acetylene fuel replacement. MagneGas 2 has the hottest known flame temperature. ( 10,500 F, as verified by City College of New York.) Higher flame temperature provides: Cutting fuel for metal fabrication, welding, demolition Safer operation with less slag and grinding Cuts 40% faster than acetylene or propane, as verified by the Edison Welding Institute. NASDAQ:MNGA Increased fossil fuel efficiency (co - combustion) Waste sterilization Additional uses due to higher temperature:

9 Disrupting an Entrenched Market MagneGas was first introduced in 2010 through third party US distributors Gained traction with 28 leading independent distributors by 2014 Disruptive Product Differentiator $31 of ancillary sales for every dollar of proprietary gas sold. Accelerated Growth Organic sales growth at ~50% CAGR vs. industry norm of US GDP ~2% Market Share Continually increasing market share in every market we serve NASDAQ:MNGA

10 Existing Captive Sales & Distributor Network California Very strong existing sales of MagneGas Tennessee Major regional distributor added in late 2016 Key driver for market penetration in 7 SE states Indiana Strong distributor penetrated market for MagneGas Big 3 auto manufacturer adopted MagneGas for 2 plants Launched organic expansion in late Q Florida Growth in revenues more than 100% Opened 3 new locations in last twelve months Texas 1 st distributor to purchase a production plant NASDAQ:MNGA

11 2017 US Growth Strategy Acquisition Criteria: Experienced sales team. Modern asset base, infrastructure Stable, profitable customer base Ability to cross - sell products Acquisition Structure: Limit upfront cash payment to ~NBV of assets Additional consideration: combination of stock, earn outs, seller notes, etc. Limit purchase price to 1.5x to 1.75x LTM revenues NASDAQ:MNGA

12 MagneGas Plasma Arc Sterilization Extremely effective sterilization with MagneGas Plasma Arc Flow System Small footprint with a very low residence time. The Plasma Arc generates a combination of very high heat, ultraviolent light, hydrogen peroxide and ozone. These are powerful sterilizers that have a proven ability to eliminate virtually all living organisms, including e coli, fecal coliform, other EPA and USDA regulated pathogens. Arc proven to break down pharmaceuticals. Potential to breakdown PCBs. NASDAQ:MNGA

13 U.S. Sterilization Pilots Indiana Pilot with largest swine farm in the state ( ) Verified our process works at scale, eliminates e coli, fecal coliform, impacts TSS. Meets EPA standards. Enables hog manure to be treated as a Class A waste. 18 month pilot with one of the largest dairy farms in Florida (Q2-2017) Awarded $430k grant Key step to obtain USDA Subsidized Equipment Eligibility Service - based model test in North Carolina (Target launch Q1, 2018) Seek to monetize the sterilization process through service, manure feedstock and reclaimed water. 1,700 hog farms in local market for early adoption and scalability NASDAQ:MNGA

14 International Unit Sales Pipeline Europe Germany: Initial purchase announced for gasification unit Italy: Initial purchase announced for sterilization unit for landfill leachates Caribbean & Latin America Trinidad & Tobago: Discussions for gasification units for acetylene replacement hub for the Caribbean Belize: Initial Discussions for sterilization units for the aquaculture industry Brazil: Discussions for gasification units Costa Rica: Inquiries for human & animal waste sterilization. NASDAQ:MNGA

15 World Class Client Adoption NASDAQ:MNGA

16 Near Term Catalysts MagneGas Technology New feedstock improved production rates by over 150% and reduces costs by over 50% Global Sales 300kw gasification unit being delivered to Germany in Q4, kw sterilization unit being delivered to Italy in in Q4, 2017 US Acquisitions Targeting 2 acquisitions on West Coast and 1 in South by FYE, 2017 NASDAQ:MNGA

17 Financial Results NASDAQ:MNGA Millions Revenue

18 Investment Highlights x Breakthrough technology reinforced by strong IP portfolio x Rapid organic growth and entry into new verticals x Lean operating structure x Accretive acquisition strategy x Highly scalable business model x Clean capital structure NASDAQ:MNGA

19 Key Statistics NASDAQ:MNGA Exchange Nasdaq Current Price (06/06/17): $0.58 Shares Outstanding: 12.2 MM Market Cap (06/06/17): $7.1 MM Insider Ownership: 11.6% Fiscal Year End: Dec 31

20 For additional info, please contact: Crescendo Communications, LLC 626 RXR Plaza Uniondale, NY T: mnga@crescendo - ir.com